BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29484542)

  • 21. The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation.
    Jacola LM; Conklin HM; Krull KR; Pei D; Cheng C; Reddick WE; Pui CH; Jeha S
    J Clin Oncol; 2022 Dec; 40(36):4218-4227. PubMed ID: 36322880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone deficiency and neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia.
    Krull KR; Li C; Phillips NS; Cheung YT; Brinkman TM; Wilson CL; Armstrong GT; Khan RB; Merchant TE; Sabin ND; Srivastava D; Pui CH; Robison LL; Hudson MM; Sklar CA; Chemaitilly W
    Cancer; 2019 May; 125(10):1748-1755. PubMed ID: 30690723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of child executive functions to parenting capacities in childhood acute lymphoblastic leukemia survivors.
    Sharkey CM; Clawson AH; Mullins LL; Brinkman TM; Pui CH; Hudson MM; Krull KR
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27761. PubMed ID: 31033172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapy.
    Iijima M; Liu W; Panetta JC; Hudson MM; Pui CH; Srivastava DK; Krull KR; Inaba H
    Cancer; 2021 Sep; 127(17):3202-3213. PubMed ID: 33914910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.
    Krull KR; Bhojwani D; Conklin HM; Pei D; Cheng C; Reddick WE; Sandlund JT; Pui CH
    J Clin Oncol; 2013 Jun; 31(17):2182-8. PubMed ID: 23650422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
    J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain Network Connectivity and Executive Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
    Kesler SR; Ogg R; Reddick WE; Phillips N; Scoggins M; Glass JO; Cheung YT; Pui CH; Robison LL; Hudson MM; Krull KR
    Brain Connect; 2018 Aug; 8(6):333-342. PubMed ID: 29936880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.
    Buizer AI; de Sonneville LM; Veerman AJ
    Pediatr Blood Cancer; 2009 Apr; 52(4):447-54. PubMed ID: 19061221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
    Petrykey K; Lippé S; Robaey P; Sultan S; Laniel J; Drouin S; Bertout L; Beaulieu P; St-Onge P; Boulet-Craig A; Rezgui A; Yasui Y; Sapkota Y; Krull KR; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
    PLoS One; 2019; 14(6):e0217314. PubMed ID: 31181069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired brain metabolism and neurocognitive function in childhood leukemia survivors despite complete hormone supplementation in adulthood.
    Follin C; Erfurth EM; Johansson A; Lätt J; Sundgren PC; Österberg K; Spulber G; Mannfolk P; Björkman-Burtscher IM
    Psychoneuroendocrinology; 2016 Nov; 73():157-165. PubMed ID: 27498291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Anesthesia Exposure and Neurocognitive and Neuroimaging Outcomes in Long-term Survivors of Childhood Acute Lymphoblastic Leukemia.
    Banerjee P; Rossi MG; Anghelescu DL; Liu W; Breazeale AM; Reddick WE; Glass JO; Phillips NS; Jacola LM; Sabin ND; Inaba H; Srivastava D; Robison LL; Pui CH; Hudson MM; Krull KR
    JAMA Oncol; 2019 Oct; 5(10):1456-1463. PubMed ID: 31219514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia.
    Jain N; Brouwers P; Okcu MF; Cirino PT; Krull KR
    Cancer; 2009 Sep; 115(18):4238-45. PubMed ID: 19536898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
    Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
    Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia.
    Cheung YT; Khan RB; Liu W; Brinkman TM; Edelmann MN; Reddick WE; Pei D; Panoskaltsis-Mortari A; Srivastava D; Cheng C; Robison LL; Hudson MM; Pui CH; Krull KR
    JAMA Oncol; 2018 Jul; 4(7):e180089. PubMed ID: 29596541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.
    Krull KR; Brinkman TM; Li C; Armstrong GT; Ness KK; Srivastava DK; Gurney JG; Kimberg C; Krasin MJ; Pui CH; Robison LL; Hudson MM
    J Clin Oncol; 2013 Dec; 31(35):4407-15. PubMed ID: 24190124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.
    Viola A; Balsamo L; Neglia JP; Brouwers P; Ma X; Kadan-Lottick NS
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):174-178. PubMed ID: 28085741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High occurrence of sleep problems in survivors of a childhood brain tumor with neurocognitive complaints: The association with psychosocial and behavioral executive functioning.
    van Kooten JAMC; Maurice-Stam H; Schouten AYN; van Vuurden DG; Granzen B; Gidding C; de Ruiter MA; van Litsenburg RRL; Grootenhuis MA
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27947. PubMed ID: 31418996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Bacteremic Sepsis With Long-term Neurocognitive Dysfunction in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Cheung YT; Eskind A; Inaba H; Hudson MM; Pui CH; Krull KR; Wolf J
    JAMA Pediatr; 2018 Nov; 172(11):1092-1095. PubMed ID: 30264151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Kunin-Batson A; Kadan-Lottick N; Neglia JP
    Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.